Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Lundbeck and Biotie sign agreement for nalmefene

Nov. 29, 2006

New series of synthetic CLIP-derived peptides disclosed in recent patent

Nov. 27, 2006

Novel CYP2A inhibitors for smoking cessation patented by InflaZyme

Nov. 2, 2006

Probuphine begins phase III trial for treatment of opioid dependence

Oct. 30, 2006

Sazetidine-A: a new desensitizing nicotinic ligand

Oct. 26, 2006

Novel sigma receptor antagonists combat cocaine-induced behavioral toxicity

Oct. 23, 2006

Desoxypeganine shows good pharmacokinetic profile in healthy volunteers

Oct. 11, 2006

Lofexidine studied for treatment of opiate withdrawal symptoms in phase III trial

Oct. 11, 2006

European approval for Suboxone for treatment of opioid dependence

Oct. 6, 2006

Alkermes developing oral products for treatment of addiction

Oct. 5, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...